1-15 of 31
Mechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
CME/CEMechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
CME/CE Broadcast ReplayMoving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Roger McIntyre, MD
Emmanuel Mignot, MD, PhD
Chairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
CME/CEChairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
Jose Rubio, MD
Simple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
CME/CESimple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Movements With Meaning: Reading the Pattern, Not the Label
CME/CEMovements With Meaning: Reading the Pattern, Not the Label
Karen E. Anderson, MD
Hubert H. Fernandez, MD
The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
MinuteCE®The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
Tracy Hicks, DNP, MBA
Melissa Moody, MD
- advertisement
Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
MinuteCE®Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Tracy Hicks, DNP, MBA
Melissa Moody, MD
When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
MinuteCE®When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
Tracy Hicks, DNP, MBA
Rethinking Schizophrenia Treatment Through Muscarinic Modulation
CME/CERethinking Schizophrenia Treatment Through Muscarinic Modulation
Jose Rubio, MD
Jonathan M. Meyer
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CEMuscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Jose Rubio, MD
Updates in Major Depressive Disorder with Insomnia
CME/CEUpdates in Major Depressive Disorder with Insomnia
Michael E. Thase, MD
Andrew Krystal, MD
- advertisement
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CEAre All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD
Jonathan M. Meyer
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast ReplayFrom Resistance to Response: Evolving Strategies in MDD Management
Joseph F. Goldberg, MD
Raman Sankar, MD, PhD
Scott Aaronson, MD
